BioCentury This Week is hosted by Washington Editor Steve Usdin and Publisher Eric
Pierce, both 19 year veterans of BioCentury. They are supported by BioCentury's
network of senior scientific and business editors recognized for their deep knowledge
and understanding of biotechnology: its science, its history and its players.
BioCentury This Week programming is overseen by BioCentury's founders, Chairman
& Editor-in-Chief Karen Bernstein, Ph.D., and President & CEO David Flores, both
globally recognized for their efforts to provide an objective, accurate and authoritative
information platform for key decision makers in bioindustry.
BioCentury This Week Anchors
Senior Editor (Washington)
Steve Usdin is BioCentury's original Washington Editor. He has devoted more than
20 years to covering political and policy issues affecting the life sciences sector,
and has earned the reputation as the industry's most respected writer/analyst on
public policy, regulatory reform and regulatory innovation.
Eric Pierce joined BioCentury in 1993, quickly becoming the company's chief financial
writer. He originated "Ebb & Flow," BioCentury's weekly capital markets report.
Eric also served as Senior Editor for News, managing BioCentury's news operations.
In 2007, he was named Publisher and is responsible for BioCentury's conferences
and business services.
BioCentury This Week Executive Editors
Co-Founder, President & CEO
David has devoted more than 20 years developing information products for biotechnology
executives and investors. He is a graduate of the University of California at Berkeley
and holds an MBA from Stanford University.
David is a member of the Advisory Board of the Innovation and New Ventures Office
(INVO) at Northwestern University and a member of the Advisory Council of the Keck
Graduate Institute of the Applied Life Sciences.
He also has served as a member of the Stanford Graduate School of Business Management
Board. In 1996, David and BioCentury Co-Founder, Chairman & Editor-in-Chief Karen
Bernstein were honored with the Special Recognition Award given by the annual gathering
of biotechnology chief executive officers in Laguna Niguel, California, citing BioCentury's
ongoing contributions to the industry.
Co-Founder, Chairman & Editor-in-Chief
Karen has been writing and publishing on biotechnology since 1987. She holds a Ph.D.
in political science from Stanford University, and a B.A. in politics and history
from Brandeis University, where she now is a member of the Brandeis University Science
She also is on the board of trustees of the Keck Graduate Institute. In 1996, Karen
and Co-Founder, President & CEO David Flores were honored with the Special Recognition
Award given by the annual gathering of biotechnology chief executive officers at
The Biotech Meeting in Laguna Niguel, California, citing BioCentury's ongoing contributions
to the industry.
In 2005, The Biotech Meeting CEOs inducted Karen into their Hall of Fame, citing
her lifetime contribution to the biotech community. In 2007, Karen received a Special
Recognition award at the American Liver Foundation's Salute to Excellence, honoring
individuals who have made an outstanding contribution to biotechnology and medical